Short-term succinic acid treatment mitigates cerebellar mitochondrial OXPHOS dysfunction, neurodegeneration and ataxia in a Purkinje-specific spinocerebellar ataxia type 1 (SCA1) mouse model-Reference-Cited by-同舟云学术

Short-term succinic acid treatment mitigates cerebellar mitochondrial OXPHOS dysfunction, neurodegeneration and ataxia in a Purkinje-specific spinocerebellar ataxia type 1 (SCA1) mouse model

Published:2017-12-06 Issue:12 Volume:12 Page:e0188425
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ferro Austin,Carbone Emily,Zhang Jenny,Marzouk Evan,Villegas Monica,Siegel Asher,Nguyen Donna,Possidente Thomas,Hartman Jessilyn,Polley Kailen,Ingram Melissa A.,Berry Georgia,Reynolds Thomas H.,Possidente Bernard,Frederick Kimberley,Ives Stephen,Lagalwar Sarita^ORCID

Funder

Directorate for Biological Sciences

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference61 articles.

1. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1;HT Orr;Nat Genet,1993

2. Regulation of ataxin-1 phosphorylation and its impact on biology;S Lagalwar;Methods Mol Biol,2013

3. RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1;J Park;Nature,2013

4. Phosphorylation of ATXN1 at Ser776 in the cerebellum;ND Jorgensen;J Neurochem,2009

5. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1;J Lim;Nature,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyglutamine disorders: Pathogenesis and potential drug interventions;Life Sciences;2024-05

2. New Perspectives for Antihypertensive Sartans as Components of Co-crystals and Co-amorphous Solids with Improved Properties and Multipurpose Activity;Molecular Pharmaceutics;2023-12-18

3. HD and SCA1: Tales from two 30-year journeys since gene discovery;Neuron;2023-11

4. Advances in cerebellar disorders: pre-clinical models, therapeutic targets, and challenges;Expert Opinion on Therapeutic Targets;2023-10-03

5. The complexities of investigating mitochondria dynamics in multiple sclerosis and mouse models of MS;Frontiers in Neuroscience;2023-07-25